Category - Feature

Feature

Perimeter mitigating re-excisions with next-gen, AI-powered imaging breakthrough; potential FDA approval on the horizon

Perimeter Medical Imaging AI (TSX-V:PINK; OTCQX:PYNKF) is an early stage commercial growth company that is pioneering a breakthrough, ultra-high-res, AI-driven intraoperative margin visualization technology called B...

October 7, 2025

Feature

Cell One Partners guiding cell and gene therapy from breakthrough science to market impact

Consultancy Cell One Partners is helping innovators translate scientific ambition into viable commercial solutions as the cell and gene therapy industry pushes toward its next era of breakthroughs. Through deep domain...

September 30, 2025

Feature

Ilant leading obesity healthcare management with a holistic virtual approach

Closely held Ilant Health is leading a paradigm shift in how obesity and cardiometabolic conditions are treated—offering a holistic, personalized, and value-based approach that gives individuals access to...

September 23, 2025

Feature

Exousia Pro progressing scalable DNA-loaded exosomes toward the clinic

Exousia Pro (OTCPINK: MAJI) is developing a next-generation drug delivery platform using plant-based exosomes and a proprietary manufacturing process that could potentially address the biggest challenges in the...

September 16, 2025

Feature

Micoy engineering therapeutic decoys to block rogue autoantibodies

Closely held Micoy Therapeutics is advancing novel, first-in-class therapeutics to target harmful autoantibodies that induce immunodeficiency by inhibiting immune signaling molecules—type I interferons—which are...

September 9, 2025

Feature

Likarda seeks acquisition partner to accelerate cell therapy delivery breakthrough

Closely held Likarda is advancing a novel modality for delivering cellular therapies—a proprietary, customizable hydrogel delivery system engineered for controlled release, immune protection, and high cell viability.

September 2, 2025

Feature

Solu developing a powerful new therapeutic modality that unlocks cell surface targets

Closely held Solu Therapeutics is pairing heterobifunctional small molecules with monoclonal antibodies to develop therapeutic agents that eliminate disease-driving cells in cancer, immunology, and other therapeutic...

August 19, 2025

Feature

Ascentage reviving programmed cell death with novel approach to hematologic malignancies

Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855) is advancing its proprietary drug discovery platform of first- and best-in-class small molecule therapies to address unmet medical needs in cancers and other diseases.

August 12, 2025

Feature

Light AI turning smartphones into portable diagnostic labs for infectious disease detection

Light AI (CBOE CA: ALGO; FSE: 0H6; OTCQB: OHCFF) is developing cutting-edge artificial intelligence (AI) to advance health diagnostics and wellness solutions through its proprietary technology platform. By applying AI...

August 5, 2025

Feature

Bioxytran disrupting infectious disease and inflammation with carbohydrate-based therapeutics

Bioxytran Inc. (OTCQB: BIXT) is pioneering the use of complex carbohydrate-based therapeutics to address urgent unmet medical needs in virology, cancer metastasis, and oxygen transport.

July 29, 2025

Category - Feature

Subscribe